u/OutlandishnessSalt92

Reddit r/wallstreetbets
· tracked since Jan 2026
Calls
1
Win Rate
100.0%
return
+2.3%
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 0
Win Rate 100% Long 1 Short 0
Win Rate
7d 100%
30d 0%
90d 100%
Average Return +2.3% Long Return +2.3% Short Return -
Average Return
7d +6.6%
30d -3.5%
90d +18.4%
Visual Insights Log in to see more
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
NTLA 1ST Intellia... Intellia Therapeutics, Inc
Long
Jan 13
$12.04
+2.3%
Undervalued CRISPR stock with FDA catalyst and heavy short interest may squeeze.
The author claims Intellia (NTLA) is an undervalued CRISPR gene-editing stock and the most heavily shorted stock, with short interest around 35-39% of float. He argues the recent trial death was from septic shock due to a perforated duodenal ulcer rather than the CRISPR treatment, so the FDA hold should lift soon and trials resume, driving a rebound. Specific catalysts cited are a JP Morgan Healthcare Conference presentation tomorrow, a $1.4 million insider purchase, continued ARK buying, and multiple 2026 milestones; these plus short positioning create squeeze potential. The main risk he discusses is the prior patient death and clinical hold, but he says it is not linked to the technology.
Pharma & Biotech
REDDIT
Showing 1 of 1 calls · sorted by mentions

u/OutlandishnessSalt92 has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: NTLA.

Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology